Understanding age-related changes in multiple sclerosis (MS) may help inform treatment decisions that address normal aging and MS-related aging processes.
Clinical pharmacists integrated into multiple sclerosis care models and working alongside other providers can streamline the health care delivery process by optimizing and accelerating access to medications requiring prior authorization, can improve patient outcomes by promoting medication adherence and persistence, can enhance safety by monitoring laboratory findings and potential drug-drug interactions, and can minimize clinical workflow burden by improving process efficiency.
The use of cooling vests may limit the effects of thermosensitivity in people with multiple sclerosis, as evidenced by improved 6-minute walk test performance compared with an uncooled condition.